Welcome to IthaMaps

IthaMaps is a global epidemiology database of heamoglobinopathies, illustrating published data on a dynamic global to regional map. Country-specific information on haemoglobinopathy-related policies, prevalence, incidence and overall disease burden is given, including relative allele frequencies of specific globin mutations in each country and/or region, dynamically linked to corresponding IthaGenes entries.

IthaMaps content was supported by partnership with the HVP Global Globin 2020 Challenge

Search

Search Country: OR Search for:  Show organisations

  General information for Democratic Republic of the Congo


Democratic Republic of the Congo
Continent: Africa
Capital: Kinshasa
Population: 70916439
Area (in sq km): 2345410.0

Haemoglobinopathy-specific healthcare policy information for Democratic Republic of the Congo

Healthcare policyComment/InfoReference
Prevention programme: No
SCD newborn screening: NoThere is linkage to reproductive, maternal, newborn and child health (RMNCH) programmes. It is practiced at subnational level. Samples for screening are collected at all levels of the health system and transported to tertiary health facilities [AFR/RC70/INF.DOC/3; 30July2020]; Currently limited to pilot centres, and soon to be introduced by the Health Ministry in Kinshasa and Katanga but using a rapid test of diagnosis.
Prenatal screening: No
Antenatal screening: No
Haemoglobinopathies patient registry: NoIn 2013, SCD was added to the list of diseases reported in the National Health System of Information.
Rare disease patient registry: No
Dedicated treatment centres: Yes (National)One national dedicated centre in Kinshasa (Monkole Hospital and the SS Centre for Mixed Medicine and Anaemia (CMMASS)) and some other in the different provinces (e.g., SCD reference center at Nsendwe Hospital in Lubumbashi), but mostly in the private hospitals and not in remote areas.[PMID: 33794895]
Blood transfusion availability: Yes (National)
Iron chelation availability: No
MRI facilities: Yes (Regional)MRI are mainly located in Kinshasa in only 4 to 6 hospitals, but the cost is high.
Genetic counselling: Yes (Regional)Limited genetic counselling in some centres where there is a SCD programme.

  Prevalence and incidence of major haemoglobinopathies in Democratic Republic of the Congo

HaemoglobinopathyComment/InfoReference
Prevalence of sickle cell disease carriers: 25 % of the populationRanges between 1.4% and 25%, being lower in the East and higher in the Central and West regions.
Prevalence of α-thalassaemia carriers: 35 % of the population30% - 40% depending on the region.
Prevalence of Hb C carriers: 2.38 % of the populationEast of the Democratic Republic of Congo.[PMID: 17925082]
Expected incidence of sickle cell disease: 50000 expected affected births/year
Incidence of sickle cell disease: 38217 affected births/yearMedian value estimated using statistical model and demographic data.[PMID: 23103089]

Mutation frequencies in Democratic Republic of the Congo

No mutation frequencies are currently available for Democratic Republic of the Congo

  Organisations in Democratic Republic of the Congo

A list of all organisations in Democratic Republic of the Congo stored in the ITHANET database is shown below. For more information, click on the corresponding organisation name or visit the detailed ITHANET Organisations page

NameDepartmentOrganisation type
Centre Hospitalier Mère-Enfant MONKOLE (CEFA/MONKOLE)Centre de Formation et d’Appui SanitaireResearch Center, Medical Center, Higher Education, Diagnostic Center

 Microattributions

A/AContributor(s)DateComments
1Tshilolo, Léon2016-10-15Information on healthcare policies and the status of major haemoglobinopathies were reviewed and updated.

To provide new epidemiological information and/or report mistakes, please register/log in first or use the Contact Us form.

Important Note: The relative allele frequencies presented in IthaMaps are not calculated by ITHANET, but they are extracted from the corresponding publications. ITHANET is not responsible for any mistakes in the data. Please use this information with caution! We encourage scientists that have more detailed or updated epidemiological information to contact us.

Disclaimer: The information on this website is provided as an information resource only and must not to be used as a substitute for professional diagnosis and treatment. The ITHANET Portal and IthaMaps are not responsible or liable for any advice, course of treatment, diagnosis or any other information, services or products that an individual obtains through this website.